Role of Monoclonal Antibody "Alemtuzumab" in the Treatment of Multiple Sclerosis

This article will review current treatment options for multiple sclerosis (MS) while keeping our primary focus on alemtuzumab, as it is now approved in more than 65 countries. From a pathophysiological point of view, MS is a disabling disease impacting a patient's life both physically and menta...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cureus
Prif Awduron: Nosher, Sadia, Fuad, Sehrish, Mishra, Nupur, Alrashid, Zaid A, Rathod, Bindu, Mohan, Devyani, Basavanagowda, Deepak M, Kaur, Arveen, Heindl, Stacey E
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Cureus 2021
Pynciau:
Family/General Practice
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948316/
https://ncbi.nlm.nih.gov/pubmed/33728194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13246
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg